Vera Therapeutics, Inc.
Vera Therapeutics, Inc. (VERA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · VERA · as of Sep 30, 2025
Ownership Breakdown
182
Institutional Holders
▼ 3 vs Q2
$1.89B
Total Inst. Value
▲ $385.45M vs Q2
71.78M
Shares Outstanding
freeFloat 81.41%
65.07M
13F Shares Held
▲ 1.17M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
VERA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
AVORO CAPITAL ADVISORS LLC pharmaceutical preparations | 6.21M | 9.74% | 9.74% | $180.46B | Nov 14, 2025 | ▼ 90.0K |
BLACKROCK, INC. pharmaceutical preparations | 4.25M | 6.66% | 6.66% | $123.42B | Nov 12, 2025 | ▲ 81.7K |
KYNAM CAPITAL MANAGEMENT, LP pharmaceutical preparations | 4.03M | 6.31% | 6.31% | $117.05B | Nov 14, 2025 | ▲ 600.9K |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 3.67M | 5.75% | 5.75% | $106.55B | Nov 14, 2025 | ▼ 813.3K |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 3.64M | 5.71% | 5.71% | $105.81B | Nov 14, 2025 | ▲ 293.0K |
VANGUARD GROUP INC pharmaceutical preparations | 3.19M | 5.00% | 5.00% | $92.72B | Nov 7, 2025 | ▲ 189.5K |
FMR LLC pharmaceutical preparations | 2.84M | 4.46% | 4.46% | $82.62B | Nov 13, 2025 | ▼ 66.8K |
EVERSEPT PARTNERS, LP pharmaceutical preparations | 2.81M | 4.40% | 4.40% | $81.60B | Nov 14, 2025 | ▲ 424.8K |
SOFINNOVA INVESTMENTS, INC. pharmaceutical preparations | 2.79M | 4.38% | 4.38% | $81.19B | Nov 14, 2025 | — held |
STATE STREET CORP pharmaceutical preparations | 2.33M | 3.66% | 3.66% | $67.81B | Nov 14, 2025 | ▲ 315.9K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
29
Increased
+7.55M shares6
New Positions
first time holders10
Decreased
−7.46M shares0
Sold Out
fully exitedNet shares change (top 50)
+87.6K
+7.55M / −7.46M
Net new holders
+25
6 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
VERA insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
5
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Morrison Scott W director | May 21, 2026 | Award | 17,084 | $34.35 | $586.8K | 17.1K | Form 4 ↗ |
Cheng Andrew director | May 21, 2026 | Award | 17,084 | $34.35 | $586.8K | 17.1K | Form 4 ↗ |
SEIDENBERG BETH C director | May 21, 2026 | Award | 17,084 | $34.35 | $586.8K | 17.1K | Form 4 ↗ |
Oliger Christy J. director | May 21, 2026 | Award | 17,084 | $34.35 | $586.8K | 17.1K | Form 4 ↗ |
Meyers James R director | May 21, 2026 | Award | 17,084 | $34.35 | $586.8K | 17.1K | Form 4 ↗ |
Hall Kimball director | May 21, 2026 | Award | 17,084 | $34.35 | $586.8K | 17.1K | Form 4 ↗ |
MORRISSEY MICHAEL director | May 21, 2026 | Award | 17,084 | $34.35 | $586.8K | 17.1K | Form 4 ↗ |
ENRIGHT PATRICK G director | May 21, 2026 | Award | 17,084 | $34.35 | $586.8K | 17.1K | Form 4 ↗ |
Fordyce Marshall PRESIDENT AND CEO | May 12, 2026 | Sale | 14,219 | $36.64 | $521.0K | 221.0K | Form 4 ↗ |
Fordyce Marshall PRESIDENT AND CEO | May 12, 2026 | Sale | 4,281 | $37.09 | $158.8K | 216.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Vera Therapeutics, Inc. (VERA) is primarily owned by institutional investors, who hold approximately 90.7% of total shares outstanding. Company insiders own approximately 18.59%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Vera Therapeutics, Inc. is AVORO CAPITAL ADVISORS LLC, holding approximately 6.21 million shares — equal to 9.74% of outstanding shares — as of September 30, 2025.
A total of 182 institutional investors currently hold VERA stock, with a combined institutional value of approximately $1.89 billion as of the most recent 13F filing period.
Frequently asked questions
VERA ownershipVera Therapeutics, Inc. (VERA) is primarily owned by institutional investors, who hold approximately 90.7% of shares. The largest shareholder is AVORO CAPITAL ADVISORS LLC with a 9.74% stake. Company insiders hold 18.59%. Data sourced from SEC Form 13F as of September 30, 2025.